Breaking News Instant updates and real-time market news.

SBET

SharpLink Gaming

/

+

11:44
11/10/22
11/10
11:44
11/10/22
11:44

Entrypoint to acquire SharpLink's legacy telecommunications business

SharpLink announced that Israel-based Entrypoint South has signed a Share and Asset Purchase Agreement with the Company to acquire SharpLink's legacy Mer Telecommunications Systems business in a one-year earn-out transaction, subject to customary closing conditions and required regulatory approval from the Israel Innovation Authority. In consideration of Entrypoint acquiring all rights, title, interests and benefits to Legacy MTS, including 100% of the shares of MTS Integratrak Inc., one of the Company's US subsidiaries, it will pay SharpLink an earn-out payment equal to three times Legacy MTS' Earnings Before Interest, Taxes and Depreciation for the year ending December 31, 2023, up to a maximum earn-out payment of $1M. Legacy MTS's business concentrates on worldwide provision of telecom expense management solutions which assist enterprises and organizations to make smarter choices with their telecommunications spending at each stage of the service lifecycle, including allocation of cost, proactive budget control, fraud detection, processing payments and spending forecasting. In July 2021, SharpLink merged with Mer Telemanagement Solutions Ltd., which at the time owned the Legacy MTS business, in a go-public transaction. Following the merger, SharpLink has operated Legacy MTS and its related subsidiaries as a business unit which has been reported in financial filings as its Enterprise TEM segment. In June 2022, SharpLink's Board of Directors provided management with approval to enter into negotiations with prospective buyers of Legacy MTS due to the fact that Legacy MTS's business is not complementary nor of any strategic benefit to SharpLink's focus on the emerging U.S. sports betting and iGaming industries.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Garanti downgraded to Neutral from Overweight at JPMorgan » 04:45
03/21/23
03/21
04:45
03/21/23
04:45
TKGBY

Garanti

$1.31 /

+ (+0.00%)

JPMorgan analyst Mehmet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TKGBY Garanti
$1.31 /

+ (+0.00%)

10/26/22 Societe Generale
Garanti upgraded to Buy from Hold at Societe Generale
10/11/22 Goldman Sachs
Garanti reinstated with a Neutral at Goldman Sachs
Downgrade
Akbank downgraded to Neutral from Overweight at JPMorgan » 04:44
03/21/23
03/21
04:44
03/21/23
04:44
AKBTY

Akbank

$1.88 /

+ (+0.00%)

JPMorgan analyst Mehmet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKBTY Akbank
$1.88 /

+ (+0.00%)

05/05/22 JPMorgan
Akbank price target raised to TRY 15 from TRY 12.70 at JPMorgan
Downgrade
Newron Pharma downgraded to Add from Buy at Baader Helvea » 04:40
03/21/23
03/21
04:40
03/21/23
04:40
NWPHF

Newron Pharma

$2.80 /

+ (+0.00%)

Baader Helvea downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
TotalEnergies upgraded to Overweight from Equal Weight at Morgan Stanley » 04:37
03/21/23
03/21
04:37
03/21/23
04:37
TTE

TotalEnergies

$57.11 /

+1.0773 (+1.92%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTE TotalEnergies
$57.11 /

+1.0773 (+1.92%)

TTE TotalEnergies
$57.11 /

+1.0773 (+1.92%)

02/09/23 Morgan Stanley
TotalEnergies price target raised to EUR 66 from EUR 60 at Morgan Stanley
01/23/23 Morgan Stanley
TotalEnergies price target lowered to EUR 60 from EUR 65 at Morgan Stanley
01/19/23 JPMorgan
TotalEnergies price target raised to EUR 73 from EUR 68 at JPMorgan
01/18/23 Redburn
TotalEnergies downgraded to Sell from Buy at Redburn
TTE TotalEnergies
$57.11 /

+1.0773 (+1.92%)

TTE TotalEnergies
$57.11 /

+1.0773 (+1.92%)

TTE TotalEnergies
$57.11 /

+1.0773 (+1.92%)

Downgrade
Agree Realty downgraded to Market Perform from Outperform at JMP Securities » 04:34
03/21/23
03/21
04:34
03/21/23
04:34
ADC

Agree Realty

$68.85 /

+0.5 (+0.73%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADC Agree Realty
$68.85 /

+0.5 (+0.73%)

ADC Agree Realty
$68.85 /

+0.5 (+0.73%)

03/09/23 Mizuho
Agree Realty price target lowered to $73 from $78 at Mizuho
02/15/23 Stifel
Agree Realty price target raised to $77.50 from $76.75 at Stifel
12/08/22 Mizuho
Agree Realty price target raised to $73 from $68 at Mizuho
12/05/22 Truist
Agree Realty price target lowered to $80 from $84 at Truist
ADC Agree Realty
$68.85 /

+0.5 (+0.73%)

  • 29
    Sep
  • 26
    May
ADC Agree Realty
$68.85 /

+0.5 (+0.73%)

Upgrade
Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley » 04:32
03/21/23
03/21
04:32
03/21/23
04:32
META

Meta Platforms

$197.76 /

+2.2 (+1.12%)

Morgan Stanley upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
META Meta Platforms
$197.76 /

+2.2 (+1.12%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

03/20/23 Loop Capital
Meta Platforms price target raised to $220 from $188 at Loop Capital
03/20/23 Edward Jones
Meta Platforms upgraded to Buy from Hold at Edward Jones
03/17/23 TD Cowen
Meta Platforms price target raised to $190 from $175 at TD Cowen
03/16/23 Benchmark
Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
META Meta Platforms
$197.76 /

+2.2 (+1.12%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

Downgrade
Svenska Handelsbanken downgraded to Equal Weight from Overweight at Barclays » 04:29
03/21/23
03/21
04:29
03/21/23
04:29
SVNLY

Svenska Handelsbanken

$4.56 /

+0.12 (+2.70%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SVNLY Svenska Handelsbanken
$4.56 /

+0.12 (+2.70%)

SVNLY Svenska Handelsbanken
$4.56 /

+0.12 (+2.70%)

02/20/23 Keefe Bruyette
Handelsbanken downgraded to Underperform from Market Perform at Keefe Bruyette
02/09/23 Barclays
Svenska Handelsbanken price target raised to SEK 115 from SEK 113 at Barclays
01/03/23 Barclays
Svenska Handelsbanken price target lowered to SEK 113 from SEK 116 at Barclays
12/06/22 JPMorgan
Svenska Handelsbanken price target raised to SEK 110 from SEK 105 at JPMorgan
Upgrade
Nordea Bank upgraded to Overweight from Equal Weight at Barclays » 04:28
03/21/23
03/21
04:28
03/21/23
04:28
NRDBY

Nordea Bank

$11.05 /

+0.25 (+2.31%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRDBY Nordea Bank
$11.05 /

+0.25 (+2.31%)

NRDBY Nordea Bank
$11.05 /

+0.25 (+2.31%)

03/07/23 Deutsche Bank
Nordea Bank price target raised to EUR 14 from EUR 13.50 at Deutsche Bank
02/27/23 JPMorgan
Nordea Bank price target raised to SEK 150 from SEK 145 at JPMorgan
02/09/23 JPMorgan
Nordea Bank price target raised to SEK 145 from SEK 135 at JPMorgan
02/03/23 Barclays
Nordea Bank price target raised to EUR 11.50 from EUR 10.70 at Barclays
General news
Market Update: » 02:45
03/21/23
03/21
02:45
03/21/23
02:45
$ECON

Economic Data

/

+

Market Update: Investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Periodicals
Treasury considering expanding FDIC coverage to all deposits, Bloomberg reports » 20:56
03/20/23
03/20
20:56
03/20/23
20:56
SPY

SPDR S&P 500 ETF Trust

$393.67 /

+3.55 (+0.91%)

, SPX

S&P 500

/

+

, QQQ

Invesco QQQ Trust

$305.90 /

+1.0522 (+0.35%)

, KRE

SPDR S&P Regional Banking ETF

$43.60 /

+0.17 (+0.39%)

, XLF

Financial Select Sector

$31.18 /

+0.235 (+0.76%)

The U.S. Treasury…

The U.S. Treasury Department is looking into whether the federal regulators are able to insure banking deposits beyond the current $250K FDIC cap, Bloomberg's Saleha Mohsin and Sridhar Natarajan report, citing people familiar with discussions. The report states that the emergency authority is being sought by a coalition of banks, claiming that it is needed to prevent a potential financial crisis. Under one legal framework that is being considered for expanding FDIC insurance, regulators would use the Treasury Department's authority to take emergency action and lean on the Exchange Stabilization Fund. Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$393.67 /

+3.55 (+0.91%)

SPX S&P 500
/

+

QQQ Invesco QQQ Trust
$305.90 /

+1.0522 (+0.35%)

KRE SPDR S&P Regional Banking ETF
$43.60 /

+0.17 (+0.39%)

SPY SPDR S&P 500 ETF Trust
$393.67 /

+3.55 (+0.91%)

03/20/23 Citi
Citi sees 25 basis point hike from Fed on Wednesday
03/17/23 JPMorgan
JPMorgan expects 25 point hike from Federal Reserve next week
03/07/23 JPMorgan
JPMorgan says 'spooked' Powell opened door to 50 point hike
02/13/23 JPMorgan
Stock market risk/reward 'skewed to the downside,' says JPMorgan
SPX S&P 500
/

+

QQQ Invesco QQQ Trust
$305.90 /

+1.0522 (+0.35%)

04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
KRE SPDR S&P Regional Banking ETF
$43.60 /

+0.17 (+0.39%)

XLF Financial Select Sector
$31.18 /

+0.235 (+0.76%)

SPY SPDR S&P 500 ETF Trust
$393.67 /

+3.55 (+0.91%)

QQQ Invesco QQQ Trust
$305.90 /

+1.0522 (+0.35%)

SPY SPDR S&P 500 ETF Trust
$393.67 /

+3.55 (+0.91%)

XLF Financial Select Sector
$31.18 /

+0.235 (+0.76%)

SPX S&P 500
/

+

QQQ Invesco QQQ Trust
$305.90 /

+1.0522 (+0.35%)

KRE SPDR S&P Regional Banking ETF
$43.60 /

+0.17 (+0.39%)

XLF Financial Select Sector
$31.18 /

+0.235 (+0.76%)

SPY SPDR S&P 500 ETF Trust
$393.67 /

+3.55 (+0.91%)

QQQ Invesco QQQ Trust
$305.90 /

+1.0522 (+0.35%)

Recommendations
Lennar price target raised to $123 from $113 at Citi » 20:51
03/20/23
03/20
20:51
03/20/23
20:51
LEN

Lennar

$102.25 /

-1.23 (-1.19%)

Citi analyst Anthony…

Citi analyst Anthony Pettinari raised the firm's price target on Lennar to $123 from $113 and keeps a Buy rating on the shares. Citing "encouraging" quarter-to-date trends, the analyst increased estimates for the firm's builder coverage. Citi sees strong spring demand for the sector.

ShowHide Related Items >><<
LEN Lennar
$102.25 /

-1.23 (-1.19%)

LEN Lennar
$102.25 /

-1.23 (-1.19%)

03/17/23 RBC Capital
Lennar price target raised to $85 from $76 at RBC Capital
03/16/23 BTIG
Lennar price target raised to $120 from $116 at BTIG
03/16/23 Credit Suisse
Lennar price target raised to $96 from $88 at Credit Suisse
03/01/23 Oppenheimer
Lennar initiated with a Perform at Oppenheimer
LEN Lennar
$102.25 /

-1.23 (-1.19%)

LEN Lennar
$102.25 /

-1.23 (-1.19%)

LEN Lennar
$102.25 /

-1.23 (-1.19%)

Recommendations
Bechtle price target raised to EUR 53 from EUR 51 at Jefferies » 20:43
03/20/23
03/20
20:43
03/20/23
20:43
BECTY

Bechtle

$7.89 /

+ (+0.00%)

Jefferies analyst Martin…

Jefferies analyst Martin Comtesse raised the firm's price target on Bechtle to EUR 53 from EUR 51 and keeps a Buy rating on the shares. The company's FY22 results and outlook for 5%-10% growth in top- and bottom line provided a "reassuring message" that IT budgets remain robust and supply continues to improve, the analyst tells investors in a research note.

ShowHide Related Items >><<
BECTY Bechtle
$7.89 /

+ (+0.00%)

01/24/23 Deutsche Bank
Bechtle price target raised to EUR 53 from EUR 52 at Deutsche Bank
11/28/22 BofA
Bechtle initiated with a Neutral at BofA
11/21/22 Exane BNP Paribas
Bechtle downgraded to Neutral from Outperform at Exane BNP Paribas
11/14/22 Berenberg
Bechtle price target lowered to EUR 43 from EUR 47 at Berenberg
Hot Stocks
Cathie Wood's ARK Investment bought 424.7K shares of Cerus today  20:31
03/20/23
03/20
20:31
03/20/23
20:31
CERS

Cerus

$2.90 /

-0.02 (-0.68%)

 
ShowHide Related Items >><<
CERS Cerus
$2.90 /

-0.02 (-0.68%)

CERS Cerus
$2.90 /

-0.02 (-0.68%)

01/20/23 BTIG
Cerus downgraded to Neutral from Buy at BTIG
CERS Cerus
$2.90 /

-0.02 (-0.68%)

CERS Cerus
$2.90 /

-0.02 (-0.68%)

Hot Stocks
Cathie Wood's ARK Investment bought 41K shares of Microsoft today  20:30
03/20/23
03/20
20:30
03/20/23
20:30
MSFT

Microsoft

$272.20 /

-7.21 (-2.58%)

 
ShowHide Related Items >><<
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

03/20/23 Stifel
Alphabet resumed with a Buy at Stifel
03/20/23 Evercore ISI
Microsoft price target raised to $295 from $280 at Evercore ISI
03/17/23 Mizuho
Microsoft price target raised to $315 from $300 at Mizuho
03/16/23 Macquarie
Microsoft 'clear winner' in ongoing generative AI fight, says Macquarie
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

Hot Stocks
Cathie Wood's ARK Investment bought 181K shares of Teladoc today  20:30
03/20/23
03/20
20:30
03/20/23
20:30
TDOC

Teladoc

$24.37 /

-0.185 (-0.75%)

 
ShowHide Related Items >><<
TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

03/10/23 Credit Suisse
Teladoc price target lowered to $27 from $30 at Credit Suisse
03/06/23 Canaccord
Teladoc price target lowered to $36 from $40 at Canaccord
03/06/23 Wells Fargo
Teladoc price target lowered to $23 from $28 at Wells Fargo
02/27/23 Deutsche Bank
Teladoc price target lowered to $27 from $31 at Deutsche Bank
TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

Hot Stocks
Enovix director buys $757K in common stock » 20:28
03/20/23
03/20
20:28
03/20/23
20:28
ENVX

Enovix

$10.83 /

-0.4 (-3.56%)

In a regulatory filing,…

In a regulatory filing, Enovix disclosed that its director Thurman Rodgers bought 69.6K shares of common stock on March 20th in a total transaction size of $757.

ShowHide Related Items >><<
ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

02/23/23 Craig-Hallum
Enovix price target lowered to $15 from $23 at Craig-Hallum
02/23/23 Piper Sandler
Enovix price target raised to $25 from $22.50 at Piper Sandler
01/26/23 JPMorgan
Enovix price target lowered to $16 from $28 at JPMorgan
01/23/23 Piper Sandler
Enovix price target lowered to $22.50 from $26.50 at Piper Sandler
ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

Hot Stocks
Snap COO sells $763.9K in common stock » 19:09
03/20/23
03/20
19:09
03/20/23
19:09
SNAP

Snap

$10.65 /

-0.045 (-0.42%)

In a regulatory filing,…

In a regulatory filing, Snap disclosed that its COO Jerry Hunter sold 69.8K shares of common stock on March 16th in a total transaction size of $763.9K.

ShowHide Related Items >><<
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

03/16/23 Benchmark
Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
03/09/23 Piper Sandler
Piper says TikTok ownership change would have negligible value impact on peers
02/14/23 BofA
Snap analyst day an opportunity to reset targets, says BofA
02/01/23 Truist
Snap price target lowered to $8 from $10 at Truist
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

Hot Stocks
Snap CFO sells $539K in common stock » 19:08
03/20/23
03/20
19:08
03/20/23
19:08
SNAP

Snap

$10.65 /

-0.045 (-0.42%)

In a regulatory filing,…

In a regulatory filing, Snap disclosed that its CFO Derek Andersen sold 49.2K shares of common stock on March 16th in a total transaction size of $539.2K.

ShowHide Related Items >><<
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

03/16/23 Benchmark
Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
03/09/23 Piper Sandler
Piper says TikTok ownership change would have negligible value impact on peers
02/14/23 BofA
Snap analyst day an opportunity to reset targets, says BofA
02/01/23 Truist
Snap price target lowered to $8 from $10 at Truist
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

Recommendations
Pinduoduo price target lowered to $115 from $127 at Citi » 18:50
03/20/23
03/20
18:50
03/20/23
18:50
PDD

Pinduoduo

$78.90 /

-13.01 (-14.16%)

Citi lowered the…

Citi lowered the firm's price target on Pinduoduo to $115 from $127 but keeps a Buy rating on the shares. The analyst states that considering the challenging macro and COVID-disrupted Q4, the 38% growth in online marketing revenue and 86% growth in commission fee revenue that drove the 43% growth in profit are stronger than the company's peers. Citi warns however that the higher base and higher expenses related to fast expansion plans of Temu are likely to weigh on Pinduoduo margins.

ShowHide Related Items >><<
PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

03/02/23 Morgan Stanley
Pinduoduo upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 KGI Securities
Pinduoduo upgraded to Outperform from Neutral at KGI Securities
11/30/22 Barclays
Pinduoduo price target raised to $84 from $70 at Barclays
11/29/22 Benchmark
Pinduoduo price target raised to $112 from $107 at Benchmark
PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

Recommendations
MacroGenics price target raised to $12 from $6 at BTIG » 18:47
03/20/23
03/20
18:47
03/20/23
18:47
MGNX

MacroGenics

$6.70 /

+0.05 (+0.75%)

BTIG analyst Kaveri…

BTIG analyst Kaveri Pohlman raised the firm's price target on MacroGenics to $12 from $6 and keeps a Buy rating on the shares. The firm said that small modifications to both MGD024 and lorigerlimab increases its interest in the pipeline. BTIG added that it raised its price target on better visibility into MGC018's commercial opportunity.

ShowHide Related Items >><<
MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

03/20/23 Citi
MacroGenics price target raised to $8 from $7 at Citi
03/20/23 H.C. Wainwright
MacroGenics price target raised to $14 from $12 at H.C. Wainwright
03/17/23 Guggenheim
MacroGenics downgraded to Neutral at Guggenheim on prostate cancer caution
03/17/23 Guggenheim
MacroGenics downgraded to Neutral from Buy at Guggenheim
MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

Recommendations
WeWork price target lowered to $3 from $7.50 at BTIG » 18:46
03/20/23
03/20
18:46
03/20/23
18:46
WE

WeWork

$1.01 /

+0.0348 (+3.57%)

BTIG analyst Thomas…

BTIG analyst Thomas Catherwood lowered the firm's price target on WeWork to $3 from $7.50 and keeps a Buy rating on the shares. The firm said that dilution is painful, but it views recapitalization as a vote of confidence.

ShowHide Related Items >><<
WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

02/16/23 Piper Sandler
WeWork shares should outperform on results, says Piper Sandler
01/03/23 BTIG
WeWork named Top Pick for first half of 2023 at BTIG
12/21/22 Cantor Fitzgerald
WeWork weakness an attractive buying opportunity, says Cantor Fitzgerald
11/04/22 BTIG
WeWork initiated with a Buy at BTIG
WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

Periodicals
Judge says JPMorgan, Deutsche will have to face Epstein lawsuits, Reuters says » 18:29
03/20/23
03/20
18:29
03/20/23
18:29
JPM

JPMorgan

$127.09 /

+1.32 (+1.05%)

, DB

Deutsche Bank

$9.92 /

+0.03 (+0.30%)

U.S. District Judge Jed…

U.S. District Judge Jed Rakoff in Manhattan determined that JPMorgan (JPM) and Deutsche Bank (DB) will have to face lawsuits accusing the banks of enabling Jeffrey Epstein's sex trafficking, Reuters' Jonathan Stempel reports. The decision could expose the two lenders to additional financial and reputational damage for maintaining Epstein as a client, the author notes. In his order, Rakoff said JPMorgan must face a lawsuit by the U.S. Virgin Islands that claims the bank missed red flags about Epstein's abuse of women on Little St. James, the author says, noting that the judge also ruled both companies must face proposed class actions by women who said Epstein abused them. Reference Link

ShowHide Related Items >><<
JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

03/13/23 Wells Fargo
Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
03/13/23 Wells Fargo
JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
02/24/23 Morgan Stanley
JPMorgan price target raised to $173 from $167 at Morgan Stanley
02/08/23 Keefe Bruyette
Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

02/10/23 BofA
Deutsche Bank downgraded to Underperform from Neutral at BofA
02/08/23 UBS
Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS
02/03/23 Credit Suisse
Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse
01/13/23 Barclays
Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays
JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

Hot Stocks
Broadcom CEO sells $18.8M in common stock » 18:26
03/20/23
03/20
18:26
03/20/23
18:26
AVGO

Broadcom

$643.63 /

+13.22 (+2.10%)

In a regulatory filing,…

In a regulatory filing, Broadcom disclosed that its CEO Hock Tan sold 30K shares of common stock on March 16th in a total transaction size of $18.8M.

ShowHide Related Items >><<
AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

03/03/23 OTR Global
Qualcomm displacing Broadcom for S23 components, says OTR Global
03/03/23 Truist
Broadcom price target raised to $700 from $659 at Truist
03/03/23 Susquehanna
Broadcom price target raised to $690 from $685 at Susquehanna
03/03/23 TD Cowen
Broadcom price target raised to $615 from $540 at TD Cowen
AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

Hot Stocks
First Majestic falls 17% after announcing cost cuts, suspended mining activity  18:25
03/20/23
03/20
18:25
03/20/23
18:25
AG

First Majestic

$7.44 /

+0.12 (+1.64%)

 
ShowHide Related Items >><<
AG First Majestic
$7.44 /

+0.12 (+1.64%)

AG First Majestic
$7.44 /

+0.12 (+1.64%)

02/27/23 TD Securities
First Majestic price target lowered to C$11 from C$12 at TD Securities
02/14/23 National Bank
First Majestic price target lowered to C$11 from C$14.50 at National Bank
01/20/23 BMO Capital
First Majestic price target lowered to C$9 from C$10.50 at BMO Capital
01/13/23 National Bank
First Majestic price target raised to C$14.50 from C$13 at National Bank
AG First Majestic
$7.44 /

+0.12 (+1.64%)

Hot Stocks
RA Capital reports 9.99% passive stake in Orchard Therapeutics » 18:22
03/20/23
03/20
18:22
03/20/23
18:22
ORTX

Orchard Therapeutics

$4.76 /

+0.16 (+3.48%)

RA Capital disclosed a…

RA Capital disclosed a 9.99% stake in Orchard Therapeutics, which represents over 18.56M shares. The filing does not allow for activism. Shares of Orchard Therapeutics are up 5.2% afterhours.

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

03/15/23 Stifel
Orchard Therapeutics target adjusted to $22 at Stifel after ADS ratio change
03/13/23 Oppenheimer
Orchard Therapeutics price target raised to $37 from $5 at Oppenheimer
07/18/22 Oppenheimer
Orchard Therapeutics assumed with an Outperform at Oppenheimer
05/13/22 Barclays
Orchard Therapeutics price target lowered to $4 from $6 at Barclays
ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.